CO2 Insufflation Beneficial During Colonoscopy

This article originally appeared here.
Share this content:
CO<sub>2</sub> Insufflation Beneficial During Colonoscopy
CO2 Insufflation Beneficial During Colonoscopy

WEDNESDAY, Oct. 7, 2015 (HealthDay News) -- Carbon dioxide (CO2) insufflation during colonoscopy is associated with reduced post-colonoscopy abdominal discomfort and improved patient satisfaction, according to a study published online Sept. 30 in the Journal of Gastroenterology and Hepatology.

Shuo-Wei Chen, M.D., from Chang Gung Memorial Hospital and University College of Medicine in Keelung, Taiwan, and colleagues examined the efficacy and safety of CO2 insufflation during colonoscopy in patients deeply sedated with propofol. One hundred twenty-five patients were randomized to receive CO2 or air (63 and 62, respectively) during colonoscopy. At one, three, and 24 hours after the procedure, the authors assessed post-colonoscopy abdominal pain, distention, and satisfaction, and compared the proportion of patients who were pain-free and distention-free.

The researchers found that post-colonoscopy abdominal pain, distention, and subjective satisfaction differed significantly between the groups at one and three hours after the procedure (P < 0.001 and 0.01, respectively). The proportion of patients who were pain-free and distention-free at one and three hours after the procedure was significantly higher in the CO2 group than in the air group. In the CO2 group, residual bowel gas in colon and small bowel was significantly reduced (P < 0.001). End-tidal CO2 levels did not differ between the groups before, during, or after the procedure.

"Compared to air, CO2 insufflation during colonoscopy reduced post-colonoscopy abdominal discomfort and improved patients' satisfaction," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »